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1 Abstract    19 
The exercise of non-testing approaches in Nanoparticles (NPs) hazard assessment is necessary 20 
for the risk assessment, considering cost and time efficiency, to identify, assess and classify 21 
potential risks. One strategy for investigating the toxicological properties of a variety of NPs is 22 
by means of computational tools that decode how nano-specific features relate to toxicity and 23 
enable its prediction. This literature review records systematically the data used in published 24 
studies that predict nano (eco)-toxicological endpoints using machine learning models. Instead 25 
of seeking mechanistic interpretations this review maps the pathways followed, involving 26 
biological features in relation to NPs exposure, their physico-chemical characteristics and the 27 
most commonly predicted outcomes. The results, derived from published research of the last 28 
decade, are summarized visually, providing prior-based data mining paradigms to be readily 29 













2 Introduction  40 
          Nanotechnology is one of the main 21st century emerging technologies with enormous 41 
potential for innovative applications, estimated to have an economic impact reaching $90.5 42 
billion by 2021 (McWilliams, 2017). It affects multiple applications and products leading in a 43 
rapid proliferation in the number of commercially exploited nano-embedded materials. 44 
However, NPs display high heterogeneity regarding their physicochemical (p-chem) properties 45 
in relation to toxicological effects, narrowing risk assessment for NP to an ad hoc testing 46 
process. The p-chem properties of NPs form their functionality and influence their 47 
environmental spreading, biological absorption, dissolution and (eco)toxicity (Giusti, et al., 48 
2019). Traditional hazard assessment relies mostly on the use of in vivo testing, which poses 49 
technical challenges when extrapolating to humans and ethical dilemmas and requires time and 50 
resources (Chen, et al., 2018). For these reasons, in silico methods have gained increasing 51 
popularity in the field of nanotoxicology in accordance with the 3R (Replacement, Reduction 52 
and Refinement) principles of diminishing in vivo toxicological studies. However, in silico tools 53 
are not yet accepted by regulators as a stand-alone solution but as complementary tools 54 
(Burgdorf, et al., 2019, ECHA, 2017). Implementing such alternative approaches in hazard 55 
assessment is defended by the Registration, Evaluation, Authorization and Restriction of 56 
Chemicals (REACH) regulation as exploratory or predictive tools (ECHA, 2017b). Few 57 
examples of toxicological endpoint assessments replaced by computational tools exist 58 
(Herrmann and Jayne, 2019).  59 
Nanotechnology involves the incorporation of expertise from various disciplines such as 60 
materials science, chemistry, toxicology, computational sciences and decision-making. Current 61 
interest in Integrated Approaches to Testing and Assessment (IATA), aiming at reducing animal 62 
testing, and the fundamental research for a mechanistic understanding of NPs toxicity are 63 




for new nanoforms. There is a significant momentum from scientific and policy-influencing 65 
bodies globally to promote in silico tools as alternatives methods. In addition, an expanding 66 
knowledge base which reinforces robust modeling competences in forecasting NP's properties, 67 
exposure and hazard potential would allow materials design with maximized utility and 68 
minimized toxicity (safe-by-design) (Schwarz-Plaschg, et al., 2017, Kraegeloh, et al., 2018). 69 
In recent years, the European Commission has financed modelling projects to tackle the 70 
opportunities offered by modeling the toxicity and properties of NPs (Puzyn, et al., 2018, 71 
Haase, 2018).  72 
Over the last two decades various types of machine learning models have been developed for 73 
predicting toxicological effects of nanoforms. As the use of computational tools in 74 
nanotoxicology is increasing, this article provides an extensive up-to-date review focusing on 75 
articles implementing machine learning tools that predict a toxicological endpoint. In this 76 
review the mechanistic interpretation of models is not analyzed; the goal of the manuscript is 77 
not to critically assess the available tools but rather to provide an overview of the machine 78 
learning tools in nanotoxicology featuring their inherent biological organization. The review 79 
maps existing models built for a specific category of NPs in the space of the features of the 80 
biological agent where the outcome is observed. Forthcoming nano-risk assessment is based on 81 
the system biology (target-organ assessment/specific level of biological organization). In order 82 
to identify the hazard potential on specific exposure conditions, we provide to computational 83 
nano-toxicologists a collective visual of applied machine learning tools. To our knowledge, this 84 
is the first review that breaks down the available computational tools based on the biology 85 
system in which they were implemented. We found that a number of computational tools have 86 
been applied for metals and/or metal oxides NPs, the majority of in silico studies use in vitro 87 
data, nano-specific features are gaining momentum as classic QSARs show inadequate to 88 




neural networks and regression are the most common implemented algorithms; perturbation 90 
and quasi-QSARs are promising approaches in the field of nanotoxicology; there is a deficiency 91 
and lack of harmonization in descriptions of experimental design inputs; there is an ongoing 92 
effort in substituting sparse, inhomogeneous literature data, the current common data source, 93 
with central, curated, comprehensive databases. 94 
3 Materials and Methods 95 
Search design 96 
          In order to investigate machine learning models in nanotoxicology we explored multiple 97 
sources of peer-reviewed scientific literature and reports with a systematic Boolean search of 98 
key terms (“nanoparticle”, “nanomaterial”, “in silico”, “computational”, “machine 99 
learning”, “model”) to produce specific multiple search strings. Those texts have been applied 100 
to discover studies that implement a machine learning model to predict nanotoxicity in publicly 101 
available electronic search engines (ScienceDirect, Web of Science, Google Scholar and 102 
PubMed) (Table 1). The final technical report of NanoComput project, “Evaluation of the 103 
availability and applicability of computational approaches in the safety assessment of 104 
nanomaterials”, carried out by the European Commission Joint Research Centre (JRC) was 105 
taken into consideration for studies before 2017 (Worth A., 2017).  106 
 107 
Table 1. Review protocol. 108 
Subject Description Subject Description 
Databases 









ScienceDirect), Web of 









Peer-reviewed journals and 
reports 
Search files title, abstract, keywords Time interval Last decade 
Eligibility and exclusion criteria 109 
          We focused on machine learning models predicting ecotoxicological (e.g., aquatic and 110 
terrestrial organism toxicity) and human health toxicological endpoints. In this review the 111 
endpoint is defined as: a specific biological effect defined in terms of biological target structure 112 
and associated changes in tissue structures and/or other parameters (OECD, 2009). Therefore, 113 
studies predicting properties of NPs such as solubility, dispersion, absorption, zeta potential, 114 
partition coefficients, Poisson’s ration or Young’s Modulus and environmental outcomes (e.g., 115 
bioaccumulation, degradation) were not included. The literature review utilized different 116 
inclusion criteria for studies that i) focus on the model implementation, ii) have been published 117 
during the last decade, iii) are published in English, iv) are published in peer-reviewed journals. 118 
The search was performed through title, abstract and keywords and a cursory read to evaluate 119 
the paper relevance. Furthermore, manual searches were conducted in reference lists from 120 
published literature to discover studies that might have been overlooked by the online searches. 121 
The search resulted in 86 studies implementing machine learning models for nanotoxicity 122 
prediction, published in the last decade.  123 
Computational predictive models for absorption, distribution, metabolism and excretion rely on 124 
physicochemical data and on mechanistic descriptions of the underlying biophysical and 125 




addressed in this study as it has been addressed lately elsewhere (Li, et al., 2017, Yuan, et al., 127 
2019). Different schemes are proposed for grouping NPs and reviewed elsewhere (Giusti, et 128 
al., 2019, Lamon, et al., 2018, Lamon, et al., 2018b). Lamon, et al. (2018b) reviewed published 129 
categorization schemes, grouping for read-across approaches and computational ranking of 130 
NPs. The authors stated that the limited studies that address NP similarities were based on 131 
limited datasets and the tools are not user-friendly. The authors suggested that datasets of 132 
toxicity and nano-properties should be investigated to distinguish groups of NPs. Giusti, et al. 133 
(2019) stated how computational methods e.g., for developing or endorsing initial grouping 134 
hypotheses, are usefully applied to different stages of grouping. A number of techniques can be 135 
used to predict toxicity, ranging from read-across, unsupervised and supervised methods of 136 
machine learning, to a variety of QSAR methods. 137 
Information extraction 138 
          The relative toxicity of NPs can be determined by numerous factors such as the route of 139 
exposure, dose and duration, as well as the p-chem properties. Furthermore, the experimental 140 
parameters i.e., the cell or animal model, cell line, cell type (normal or cancer), toxicological 141 
assay (MTS, MTT, etc., for in vitro) or the gender and age for in vivo assays, add further 142 
variables that may affect the outcome. In this study, each paper was reviewed and information 143 
related to the i) data extraction source (literature, database or experimental), ii) NPs category 144 
(metal, metal oxides et.), iii) nano-specific descriptors (p-chem), iv) study design experimental 145 
parameters (in vitro/in vivo, dose, cell line, tissue, etc.), v) endpoints and vi) model algorithms 146 
(neural networks, regression etc.) were extracted . The proposed work is the review of the above 147 
information on the existing studies and the representation in an integrated style. There are no 148 
definite guidelines in dataset formation and model implementation in order to create a 149 
predictive model with nanotoxicological data. A figure with all the steps, from data extraction 150 




guide for extracting and categorizing the information of the published studies in a systematic 152 
way and were adopted in this review.  153 
 154 
Figure 1. A summarized general roadmap for implementing a model in the field of 155 
nanotoxicology. The roadmap can be divided into five main parts: dataset formation overview, 156 
data pre-processing, model implementation, model validation and applicability domain. 157 
 158 
Following the general roadmap of model implementation shown in Figure 1, we discriminated 159 
five main sequential parts involved. The first step, the dataset formation, where 160 
nanotoxicological data is gathered to be used by predictive models. Sources, features of NPs, 161 
study design information and patterns of data used in the studies during the last decade were 162 
reviewed and mapped towards the five most common predicted endpoints.  163 
The remaining sequential parts of Figure 1 i.e., data pre-processing techniques, model 164 




detail elsewhere (Furxhi, et al., 2020b). The Dataset formation overview contains four subparts 166 
(Figure 1). The first part refers to the data sources used in the studies being either existing 167 
literature, databases or new data experimentally created or their combinations. In the second 168 
part the information on NPs is extracted e.g., nano-specific descriptors (size, coating, zeta 169 
potential, etc.) and the NP category (metal, metal oxide, carbon based, etc.). Besides nano-170 
specific descriptors, theoretical descriptors can be generated using available software to be used 171 
as input. Third, inputs including study design information are attained such as the testing system 172 
(in vitro, in vivo), species (human, bacteria, etc.), tissue (lung, kidney, etc.), exposure conditions 173 
(dose, duration) and in vitro experimental features (e.g., cell line: A549, Caco2, etc.). Last, the 174 
toxicological studies endpoints which are used as the output to be predicted by the models are 175 
recorded. All of the reviewed studies mentioned data sources, NP category, endpoint predicted 176 
and model algorithm chosen. In cases where the study did not mention the biological features 177 
of the experimentally measured endpoint, we tracked down the original publication of the data 178 
to find out the toxicological assay information. 179 
4 Results 180 
4.1 Dataset formation overview 181 
4.1.1  Data sources in the studies 182 
          The majority of the reviewed studies (63%) extracted data from peer-reviewed literature 183 
sources (Figure 2). A significant portion, 21%, of the studies, used new data derived 184 
experimentally either from NP synthesis and elaborated characterization or in vitro/in vivo 185 
toxicological assays. 14% of the studies exploited available datasets from nano-specific or non-186 
nanospecific databases. In contrast, only 2% of the studies used integrated data combining 187 
literature, database and experimentally produced new data. A notable share of publications 188 




single dataset from the literature (see Figure 2- Literature) used mostly data originally from 190 
(Weissleder, et al., 2005, Puzyn, et al., 2011, Walkey, et al., 2014) for the prediction of either 191 
the bacterial viability of metal oxides or the prediction of cellular uptake of florescent magnetic 192 
metal oxides. The rest of the studies handled multiple datasets extracted from different peer-193 
reviewed journals. Safe and Sustainable Nanotechnology (S2NANO)1 was the database mostly 194 
used (see Figure 2- Database); other databases such as the National Institute for Occupational 195 
Safety and Health (NIOSH)2, the Online chemical database (OCHEM)3, the Database and 196 
Ontology Framework for Nanomaterials Design and Safety Assessment (eNanoMapper)4 and 197 
Nanomaterial-Biological Interactions Knowledgebase (NBI)5 were used less.  198 
 199 
                                               
1 http://portal.s2nano.org/ (Webpage accessed autumn 2019). 
2 https://www.cdc.gov/niosh/data/default.html (Webpage accessed autumn 2019). 
3 https://ochem.eu/home/show.do (Webpage accessed autumn 2019). 
4 http://www.enanomapper.net/data (Webpage accessed autumn 2019). 




Figure 2. The percentage of data extraction sources and experimentally generated new 200 
data from the gathered studies. Additional information on the number of studies in case of 201 
literature and database data extraction is shown. 202 
4.1.2 Nanoparticle and study design information  203 
          Different categories of NPs based on chemical composition were studied during the last 204 
decade regarding their toxicity prediction using machine learning models. The data in Figure 205 
3 indicate that metal oxides (i.e., Al2O3, CuO, TiO2 ,CeO2, La2O3,  Co3O4, Cr2O3, Sb2O3, Fe2O3, 206 
Fe3O4, SnO2, Ni2O3, SiO2, Mn2O3, ZnO etc.,) were the most abundantly modelled NPs (42 207 
studies) followed by carbon based (nano-tubes and fullerenes) and metals (Au, Ag, Cu, Co, 208 
etc.,) with 10 and 12 studies, respectively. A limited number of studies dealt with dendrimers 209 
such as Poly-(amido amine) (Jones, et al., 2015), polymers (chitosan/streptokinase, Poly(N-210 
isopropylacrylamide)) (Bygd, et al., 2015, Baharifar and Amani, 2016) and quantum dots 211 
(Bilal, et al., 2019, Oh, et al., 2016). The above studies used datasets specific to one NP 212 
category; nonetheless, different categories of NPs such as metals, metal-oxides, carbon-based 213 





Figure 3. Nanoparticles categories in the datasets used for modelling in the studies 216 
gathered. The numbers demonstrate the number of studies using the specific category. The sum 217 
is higher than sum of studies gathered as some studies dealt with more than one dataset. 218 
P-chem properties can be generally categorized into intrinsic properties (core size, shape, 219 
chemical composition) related to the NP itself, extrinsic (zeta potential, purity, agglomeration) 220 
that is, properties related to the behavior of NP in the exposure media, and intermediate 221 
properties (coating, surface area, solubility) (Casals, et al., 2017). Almost half of the studies 222 
used at least one nano-specific descriptor as input. Size (measured in different media using 223 
different techniques) showed up most times (38 studies out of 86) which is evident in Figure 4 224 
since it is a common feature that has been linked to nanotoxicity. Size was followed by zeta 225 
potential and surface area given in 30 and 16 studies, respectively. Coating, shape and 226 
composition appeared as significant features in modelling, whereas agglomeration, solubility, 227 
purity and composition were not considered as much presumably due to the lack of data. 228 
Exposure conditions such as dose and exposure time were also monitored with dose appearing 229 
more frequently (27 studies). The bottom-right corner cell in Figure 4 demonstrates studies that 230 
took at least one in vitro characteristic such as cell line, cell origin, assay, cell type and species, 231 
as final input descriptor in the model. Studies typically used a combination of the 232 
aforementioned variables and selected the final descriptors for modelling after pre-processing 233 
the data and eliminating the least important features. Data pre-processing techniques and feature 234 
selection methods used in the studies are covered in greater detail elsewhere (Furxhi, et al., 235 
2020b). Protein-corona descriptors (not shown in figure) were used in two studies (Papa, et al., 236 





Figure 4. Nano-specific features used in the studies gathered. The number signifies the 239 
number of studies (out of 86) using that parameter as input in the final model.  240 
In vivo features in the study design information were not placed in the first section of Figure 1, 241 
since only a limited amount of studies used experimental in vivo information as input variables. 242 
Ten out of 86 studies referred to an in vivo system (rodent, fish, crustacean or combination of 243 
organisms); nevertheless, three of them utilized in vivo experimental information as final 244 
descriptors. Ban, et al. (2018) used the animal strain, weight, exposure route and age of rodents 245 
for the prediction of reproductive toxicity using a decision tree algorithm (random forest). 246 
Gernand and Casman (2014) utilized the animal weight for a meta-analysis prediction of carbon 247 
based NPs for four different endpoints using random forests. Liu, et al. (2013) exploited the 248 
primary exposure route to predict the post-fertilization mortality, translated in a metric based 249 
score for zebrafish. However, while other studies took a combination of in vitro - in vivo studies 250 
(Kleandrova, et al., 2014b, Kovalishyn, et al., 2018), in vivo assays have not been favored in 251 





4.1.3 Descriptors generation in the studies 254 
          Quantitative Structure-Activity Relationships (QSARs) models are based on the 255 
mathematical descriptions of the relationship between molecular structural characteristics and 256 
an effect (Christen, et al., 2014, Sizochenko, et al., 2014). Normally, the structure of NPs can 257 
be defined by both experimentally determined p-chem properties and theoretically calculated 258 
descriptors. From the 86 studies gathered half of them calculated theoretical descriptors as input 259 
variables either used as such, or in combination with nano-specific characteristics. Theoretical 260 
descriptors can be calculated using academic and commercial software (e.g., ADRIANA6, 261 
Dragon7, Cerius28, MOE9, MOPAC10, PaDEL11 etc.,) derived from NP electrical, atomic and 262 
molecular structure and their immediate environment (Gharagheizi and Alamdari, 2008, 263 
Gerber, et al., 2013, Petrova, et al., 2011). However, porting the complex and non-uniform 264 
nanostructures in computer language is a challenging and time-consuming task (Oksel, et al., 265 
2017). Density Functional Theory (DFT) as an instance of determining molecular descriptors 266 
is a method that settles among quick ad hoc, semi-empirical and time-intensive ab initio 267 
methods (Villaverde, et al., 2018, Pathakoti, et al., 2014).   268 
Quantum chemical descriptors were calculated in 18 out of 86 studies. For the ones used the 269 
most the calculations require certain quantum-chemical background (Nikota, et al., 2016). 270 
Electron distribution and affinity, band gap, electronegativity and enthalpy of formation are 271 
commonly used descriptors derived from quantum-mechanical calculations. A new approach, 272 
the Liquid Drop Model (LDM) combines specific descriptors that represent a NP 273 
supramolecular structure for different organizational levels avoiding extensive quantum-274 
                                               
6 https://www.mn-am.com/products/adrianacode. (Webpage accessed autumn 2019). 
7 https://chm.kode-solutions.net/products_dragon.php. (Webpage accessed autumn 2019). 
8 http://www-jmg.ch.cam.ac.uk/cil/SGTL/cerius2.html. (Webpage accessed autumn 2019). 
9 https://www.chemcomp.com/.  (Webpage accessed autumn 2019). 
10 http://openmopac.net/. (Webpage accessed autumn 2019). 




mechanical calculations (Sizochenko, et al., 2014). The OECD validation principles require 275 
that the exact process, followed to obtain extract descriptors, should be explicitly stated (Puzyn, 276 
et al., 2018).  277 
Descriptors to characterize NPs may be taken directly from the Chemicool12 periodic table 278 
(Jagiello, et al., 2016, Kleandrova, et al., 2014). Periodic table descriptors were used in nine 279 
studies out of 86 studies. An alternative source are images taken by transmission electron 280 
microscopy (TEM), scanning electron microscopy or atomic force microscopy (Bigdeli, et al., 281 
2015). Using images derived from TEM, quantum-mechanical and nano-specific descriptors 282 
such as shape, size, aggregation state and surface area can be generated (Jagiello, et al., 2016, 283 
Bigdeli, et al., 2015, Mikolajczyk, et al., 2015). Experimental descriptors can also be obtained 284 
from Raman spectroscopy (González-Durruthy, et al., 2017).  285 
4.1.4 Studies Endpoints 286 
         The first OECD principle of a QSAR and an in silico models in general requires a well-287 
defined endpoint. The endpoint is defined as “a measure of activity for chemicals made under 288 
specific conditions” and refers to “any physicochemical property, biological effect or 289 
environmental parameter related to chemical structure that can be measured and modelled” 290 
(OECD, 2004). In the studies gathered the predicted endpoints were in general clearly identified 291 
and several toxicological endpoints were used. The combinations of experimental in vitro 292 
parameters for each of the studies, such as species, cell type and tissue, NP category, model 293 
implementation and endpoints, were recorded independently in a worksheet resulting in 294 
multiple insertions (rows) per study. If for example, a different model with unchanged 295 
conditions was created, this was inserted as a novel case (row) within the worksheet. 296 
Alternatively, if different data-rows were used by the same model this leads to a new case in 297 
                                               




our analysis. This process resulted in the extraction of 273 predictive modelling cases 298 
implemented in 86 individual studies. All the cases are derived from the studies. A broad 299 
spectrum of in vitro assays are currently used since they are important indicators for biological 300 
evaluation. In vitro assays are cheap, rapid and reproducible covering various cell functions. 301 
Assays measure different markers, signaling the loss of membrane integrity (cytotoxicity), the 302 
number of live cells (viability assay) or cell death mechanisms (e.g., apoptosis). 303 
From the 273 cases the majority (118) was built to predict viability (Figure 5). These 118 cases 304 
were extracted from 42 individual studies. There are numerous classifications of cell viability 305 
assays, labeled as e.g., colorimetric, dye exclusion, fluorometric assays etc. In this review, we 306 
generally cited the endpoints without splitting them into further detailed assays for reasons of 307 
simplicity and clarity. The second most predicted endpoint was cellular uptake. 27 cases to 308 
predict cellular uptake were derived from 11 studies. Cellular uptake relate directly to the 309 
processes leading NPs to penetrate the cell membrane (Zhao, et al., 2011) and facilitates 310 
understanding both adverse (toxicological) and favorable (i.e., drug delivery) biological fate of 311 
NPs. Aggregated outcomes were predicted in 23 cases derived from 17 studies. The term 312 
“aggregated” refers to a combination of different endpoints in predicting a generic biological 313 
activity. Usually those studies performed weighting averages of the combined outcomes or 314 
ranking of hazard endpoints into a singular outcome. Apoptosis (the process of programmed 315 
cell death) was targeted in 15 cases derived from 2 studies and membrane integrity in 14 cases 316 
produced by 7 studies. Membrane integrity is defined as the quality or state of the complete cell 317 





Figure 5. Outcomes-nanotoxicological endpoints that are predicted in the field of 320 
computational nanotoxicology. The value next to the outcome, inside the box, is the number 321 
of model implementations (cases) preformed to predict that outcome. The number outside the 322 
box (bold) is the number of individual studies that implemented the computational tools. 323 
The rest of the outcomes (Figure 5, box surrounded with dash type lines) such as oxidative 324 
stress of metal oxides (Gajewicz, et al., 2018), mitotoxicity (mitochondrial respiration) of 325 
carbon nano-tubes (González-Durruthy, et al., 2017), exocytosis of gold NPs (Bigdeli, et al., 326 
2015, Oksel, et al., 2016), reproductive toxicity of various NPs (Ban, et al., 2018), macrophages 327 
or neutrophils counts as pulmonary toxicity indicators (Gernand and Casman, 2014), 328 
mutagenicity of carbon-based NPs (Toropov and Toropova, 2014, Toropov and Toropova, 329 
2015) etc., were targeted in less than four cases resulting from few studies. We performed a 330 
focused analysis of the top five most common nanotoxicological endpoints (viability, cellular 331 




4.2 Case mapping by endpoint overview 333 
          In the section below, information gathered from the 273 cases was further analyzed to 334 
reveal pathways through data extraction source, NP groups, level of biological organization 335 
(system, species, tissue), model implementation and endpoint metrics that lead to the top-five 336 
toxicological predicted endpoints. The review is split and presented by endpoint. 337 
The most common data mining machine learning algorithms can be clustered to categories such 338 
as rules, instance based (Inst Based), decision trees (D. Tree), bayesian networks (Bayes), 339 
neural networks (N. Network), dimensionality reduction (D. reduction), regression and 340 
meta/ensemble (Brownlee, 2013). Furxhi, et al. (2020b) gived a detailed information of the 341 
machine learning algorithms for the 273 cases. 342 
 343 
Figure 6. Case flow by attribute, featuring aggregated endpoints as a combined outcome. The 344 
width of the flows is proportional to the number of cases. The flow demonstrates what cell lines of which 345 
species were exposed to which particles, in in vivo or in vitro experiments, resulting in various endpoints 346 




codified as either binary, numerical or nominal. Liter: literature, Exper: experimental, QC: quantum-dots, 348 
comb1: dataset containing metal, metal oxides, polymeric and dendrimer NPs, comb2: dataset containing 349 
metal, metal oxides and carbon based NPs, in viv-vit: dataset containing in vivo and in vitro data 350 
          The Sankey diagram in Figure 6 shows the information flow of data starting from their 351 
extraction source through their NP types, experimental biological system and tissue studied, 352 
algorithm implemented and outcome metrics used to predict aggregated outcomes (Figure 6). 353 
Aggregated outcomes correspond to the combination of multiple endpoints under certain 354 
criteria or the combination of endpoints with experimental conditions and/or toxicities/activities 355 
(Table 2). Aggregated outcomes were mostly predicted by models using data extracted from 356 
the literature (13 cases) followed by experimental new data and databases, 5 and 4 cases, 357 
respectively (Figure 6). The largest portion of the models used datasets containing metals-metal 358 
oxides-quantum dots and metals-metal oxides, 9 and 6 cases, respectively. Over a half of the 359 
models predicted aggregated outcomes from in vitro (10 cases) systems using various species 360 
(10 cases) with multiple cell types (11 cases) (Table 2).  361 
Table 2. Terms referring to grouped values in the review: Aggregated (outcomes), NPs 362 
(Comb), species (various in Figure 6), cell lines (multiple in Figure 6) and algorithm (Meta in 363 
Figure 6, Figure 8 and Figure 10) examples. 364 
Aggregated 
(outcomes) 
Caspase-mediated apoptosis, mitochondrial membrane potential, mitochondrial 
depolarization, neurological, pulmonary, fibrosis, immunological, 
genotoxicity, inflammation, particle concentration in air and occupational 
exposure limits, Micro-Eff, membrane integrity, necrosis, haemolysis, 




Algae, bacteria, fungi, mammal, human, crustaceans, plants, fishes, protozoa, 





(cell lines or 
species 
details) 
Danio rerio, Pseudokirchneriella subcapitata, aorta, coronary artery, 
monocytes/ macrophage, liver, skin, colon, Escherichia coli, Photobacterium 
phosphoreum, Vibrio fischeri, Saccharomyces cerevisiae, Desmodesmus 
subspicatus, Chlorella vulgaris, Scenedesmus, Brassica napus, Cucumis 
sativus, Raphanus sativus, Lolium perenne, Daphnia magna, Thamnocephalus 




Comb1: metal, metal oxides, polymers and dendrimers in one dataset 
Comb2: metal, metal oxides and carbon based NPs in one dataset. 
Algorithm 
(meta) 
Bagging algorithm, Stochastic gradient boosting and majority voting. 
Combination of several different individual classifiers.  
 365 
A paradigm of perturbation models that use multiple species and cell lines to predict an 366 
aggregated outcome can be found in Concu, et al. (2017) who predicted the toxicity profile of 367 
metals-metal oxides-quantum dots NPs based on several measures such as the concentration 368 
causing i) 50% reduction in viability (CC50), ii) a response halfway between the baseline and 369 
maximum (EC50), iii) prevention of the root elongation of a plant at 50% (IC50), iv) toxic (TC50) 370 
and v) lethal (LC50) effects. The authors developed a Quantitative Structure–Toxicity 371 
Relationship (QSTR) perturbation model based on data for mammal cell lines, algae, fish, 372 
bacteria and others. Using perturbation theory and moving average analysis they defined the 373 
final descriptors based on pair-combinations differences. The outcome was clustered into a 374 
binary metric form the so called “toxic” and ‘non-toxic’. The same approach was followed in 375 
(Kleandrova, et al., 2014, Kleandrova, et al., 2017, Luan, et al., 2014). As clearly shown in 376 





In silico tools for in vivo systems (4 cases) were used for cases of fish organisms. George, et al. 379 
(2011) studied commercial metals/metal oxides with the inclusion of a quantum dot, using a 380 
multi-parametric screening assay incorporating cellular injuries (ROS production, intracellular 381 
calcium flux, mitochondrial depolarization, and plasma membrane permeability). The authors 382 
applied neural networks to estimate and compare the in vitro hazard potential. The zebrafish 383 
was used as an in vivo model to develop the hazard ranking for NPs based on the impact on 384 
zebrafish embryos.  385 
Speck-Planche, et al. (2015) used data from literature and the OCHEM database for the 386 
prediction of a binary ecotoxicological outcome using a QSAR-perturbation model based on 387 
the concentration for 50% inhibition of growth (IC50), minimum concentration preventing the 388 
visible growth (MIC) or completely killing of the bacteria (MBC) and the microbicidal effect 389 
under several experimental conditions. Available databases were also used; the NBI knowledge 390 
base  was used by (Liu, et al., 2013) for the prediction of post-fertilization mortality of zebrafish 391 
translated into a metric based score for metal, dendrimer, metal oxide and polymeric NPs 392 
(Comb1 in Figure 6); the NIOSH database combined with an EU expert consortium was used 393 
by (Murphy, et al., 2016) for the risk estimation of carbon-based, metal and metal oxide NPs 394 
(Comb2 in Figure 6). The authors used a Bayesian Network in a control banding framework. 395 
Metals-metal oxides datasets were used to create 6 models predicting aggregated outcomes 396 
using various species and multiple cell lines. Oksel, et al. (2016) described the application of a 397 
decision tree algorithm for nano-Structure–Activity Relationship (SAR) modeling using four 398 
different paradigms. The first paradigm was a dataset for the general cellular toxicity in a binary 399 
form for oxidative stress and acute pulmonary inflammation based on multi-parameter high-400 




Two cases predicted an aggregated outcome in a nominal form, as seen in Figure 6. Marvin, 402 
et al. (2017) used a Bayesian model to rank human hazard of metals-metal oxides, into low, 403 
medium, high and none (nominal metrics), based on several biological effects such as 404 
neurological, immunological, inflammation, fibrosis etc. Harper, et al. (2015) summarized 21 405 
measured ecotoxicological endpoints from zebrafish to develop an a priori weighting metric 406 
score for effect comparison implementing a decision tree algorithm. Shao, et al., 2013 applied 407 
a regression case for carbon nanotubes using several endpoints based on an activity scale to 408 
predict human toxicity in blood cells (Shao, et al., 2013).  409 
Sizochenko, et al., 2018 developed a unsupervised neural network to predict the toxicity of 410 
metal oxides regarding bacteria, algae, protozoa and mammalian cell lines. Oxidative stress and 411 
acute pulmonary inflammation were used as endpoints in (Zhang, et al., 2012) to demonstrate 412 
the effect of band gap and dissolution profiles on metal oxides toxicity using a regression tree. 413 
Fourches, et al. (2010) used an instance based algorithm to predict metal NPs impact on ATP 414 
content, reducing equivalents, caspase-mediated apoptosis and mitochondrial membrane in one 415 
dataset using biological input of dose, cell line, and assay in a combinatorial vector. 416 
In summary, aggregated outcomes were usually predicted by data extracted from the literature, 417 
mostly for metals, metal oxides and quantum dots, tested in vitro for various species and 418 
multiple cell lines thereby building up large datasets. Due to the complexity and magnitude of 419 
the data that refers to different species and aggregated outcomes, non-linear modelling was 420 
preferred, mostly neural networks and dimensionality reduction algorithms. Table 3 presents 421 
the studies with the largest datasets. The largest datasets were generated using perturbation 422 
theory. Usually the datasets in nanotoxicology are small (67% of cases had less than 200 data 423 




Table 3. Examples of cases that used large complex datasets. The row of the datasets and 425 
their accessibility. 426 
Reference Algorithm Data rows Data accessibility 
(Concu, et al., 2017) Neural 
Networks 
 
54,371 Data available as 
supplementary material (Sizochenko, et al., 2018) 184 
(George, et al., 2011) 4,032 - 




(Kleandrova, et al., 2014) 5,520 Data available as 
supplementary material (Kleandrova, et al., 2014b) 36,488 
 427 
 428 
Figure 7. Case flow by attribute, featuring apoptosis as outcome. The width of the flows is 429 
proportional to the number of cases. The flow demonstrates what cell lines of which species 430 
were exposed to which particles, in in vivo or in vitro experiments, resulting in cell apoptosis. 431 
It also shows what models were used for predicting apoptosis, codified as either a binary, 432 
numerical or nominal outcome (only numerical in this case). Liter: literature, QC-dots: quantum-433 
dots. 434 
          The Sankey diagram in Figure 7 shows the information flow for apoptosis outcome. All 435 




models were based on the apoptosis measured in human cell lines of different organ tissues, 437 
such as liver, aorta, blood and muscle. The algorithms used were neural networks and 438 
regression modelling of the dose-response curve (Hill slopes of EC50). In detail, Winkler, et al. 439 
(2014) generated a regression and a Bayesian-regularized neural network model, using four 440 
nanospecific descriptors that predict smooth muscle apoptosis induced by 50 metal oxides. The 441 
authors observed that the most influential features on prediction were the core material, coating 442 
and surface charge. Epa, et al. (2012) employed both linear and non-linear neural networks. 443 
Using all p-chem and theoretical descriptors they extracted the best models and using only 444 
interpretable descriptors, mainly size/shape of molecules and hydrogen bonding, they built two 445 
additional models. Both studies extracted data of metal oxides in endothelial and smooth muscle 446 
cells, monocytes and hepatocytes using four assays at four different concentrations per assay. 447 
In both studies only QSAR-models in smooth muscle cell apoptosis assay had results of 448 
statistical significance. Both studies took the original data from (Shaw, et al., 2008).  449 
 450 
Figure 8. Case flow by attribute, featuring cellular uptake as outcome. The width of the 451 
flows is proportional to the number of cases. The flow demonstrates what cell lines of which 452 




uptake. It also shows what models were used for predicting cellular uptake, codified as either a 454 
binary or numerical outcome. Liter: literature. 455 
          As seen in Figure 8 all the cases predicting cellular uptake extracted information from 456 
literature. The datasets comprised of metal oxides tested in human cells using different cell 457 
lines, mostly pancreatic cells. Models were created to predict the cellular uptake in a numeric 458 
form (log[NP]/cell pM, 23 cases) or in a binary form (4 cases). Linear models such as regression 459 
and non-linear i.e., neural networks, instance-based, decision trees were used. All studies used 460 
the data reported by (Weissleder, et al., 2005) for 109 superparamagnetic and dextran-coated 461 
NPs. Uptake was found to vary depending on surface modifications in PaCa2 and HUVEC of 462 
the five assays tested.  463 
Fourches, et al. (2010) investigated the uptake against different cell lines selecting the 464 
pancreatic cells for in-depth QSAR study. Employing instance based (k-nearest neighbors and 465 
support vector machine) methods from the Chemical Computing Group13 commercial software, 466 
using MOE descriptors, they demonstrated the importance of lipophilicity. Chau and Yap 467 
(2012) selected the above datasets based on three quality criteria such as, a sample size, 468 
endpoints not easily measured experimentally and data with standardized experimental protocol 469 
and developed a Quantitative Nanostructure Activity Relationship (QNAR) model. They built 470 
a consensus model (meta algorithm) based on bayes (Naive Bayes), regression (Logistic 471 
Regression) and instance based (kNN, SVM) models. The outcome of the model was in a binary 472 
form with a threshold value of 5000 NPs per cell. The same dataset was used in an ensemble 473 
QSAR model implementing stochastic gradient boosting and bagging algorithms, to predict 474 
biological effects from simple structural descriptors for a binary classification (Singh and 475 
Gupta, 2014). 476 
                                               




Epa, et al. (2012) generated regression and neural network models to predict uptake expressed 477 
as log[NP]/cell pM using molecular descriptors from several software. Ghorbanzadeh, et al. 478 
(2012) also predicted the uptake using molecular descriptors calculated with Hyperchem and 479 
DRAGON software by combining neural networks and regression techniques to correlate 480 
nanostructure with bioactivity. Toropov, et al. (2013) predicted uptake with a quasi-QSAR 481 
model in CORAL based on SMILES-based optimal descriptors. They suggested the concept of 482 
QSARs as random events as the alternative to build up QSARs with just one distribution of 483 
available data for the training and validation subsets. Winkler, et al. (2014) used a regression-484 
based QSAR model with an expectation minimization algorithm and neural networks with 485 
Gaussian or Laplacian prior to predict cellular uptake from theoretical descriptors. 486 
Melagraki and Afantitis (2014) developed a QNAR model for the prediction of the uptake using 487 
a set of molecular descriptors encoding two-dimensional structure information. Rong, et al., 488 
2015 tested linear and non-linear QSARs based on support vectors with descriptor sets selected 489 
by SFS and SFFS from an initial pool of 151 MOE descriptors for PaCa2 uptake. Finally, Oksel, 490 
et al. (2016) using the same dataset described the application of a novel decision tree algorithm 491 
for binary classification that could provide more clarity for interpreting the NP structure–492 





Figure 9. Case flow by attribute, featuring membrane integrity as outcome. The width of 495 
the flows is proportional to the number of cases. The flow demonstrates what cell lines of which 496 
species were exposed to which particles, in in vivo or in vitro experiments, resulting in affecting 497 
membrane integrity. It also shows what models were used for predicting membrane integrity, 498 
codified as either a binary, numerical or nominal outcome. Liter: literature, Exper: experimental. 499 
          Cases predicting membrane integrity are shown in Figure 9. Models to predict membrane 500 
integrity were applied for metal oxides (12 cases) and carbon based NP (2 cases) for in vitro 501 
and in vivo systems, respectively. Five cases contained new experimental data and nine cases 502 
contained literature datasets. Twelve out of 14 assays involve human and rodent lung cells and 503 
two involve liver cells. Gernand and Casman (2014) presented a regression-tree QSAR on a 504 
meta-analysis of rodent pulmonary studies of uncoated carbon nanotubes exposure. Individual 505 
endpoints were measured in bronchoalveolar lavage fluid of the mice or rats covering 506 
polymorphonuclear neutrophils, macrophages, lactate dehydrogenase (LDH) and total protein. 507 
Those endpoints associated with immune response, membrane damage and cell death were 508 
expressed in numeric form (fold of control measurements). Le, et al. (2016) studied ZnO NPs 509 




human liver. Regression and neural network models were developed to link NP features to cell 511 
viability, membrane integrity and oxidative stress. Membrane integrity was determined by LDH 512 
assay and the endpoint was predicted in numeric by plasma-membrane leakage via PI uptake 513 
against population not exposed to NPs. Liu, et al. (2011) SAR model predicted the membrane 514 
integrity in a binary form using a decision boundary to divide the input parameter space into 515 
toxic and nontoxic regions.  516 
          Toropova, et al. (2015b) using data from (Patel, et al., 2014) created a QSAR model with 517 
optimal descriptors (quasi-SMILES) for the prediction of membrane damage by propidium 518 
iodide uptake by metal-oxides. Sayes and Ivanov (2010) attempted to identify a set of properties 519 
of TiO2 and ZnO to describe and estimate the damage (via LDH release) of human lung cells 520 
implementing dimensionality reduction and regression QSARs. LDH release was categorized 521 
into four different nominal impact potentials e.g., normal or leaky (2 cases with nominal 522 
outcomes as shown in Figure 9). Toropova and Toropov (2013) used experimental data from 523 
(Sayes and Ivanov, 2010) with optimal descriptors for the prediction of membrane damage 524 
(units L-1) for various TiO2 by means of quasi-QSAR. Papa, et al. (2015) developed linear 525 
(regression) and non-linear (decision tree, neural network) QSAR modelling of the cytotoxicity 526 
of TiO2 and ZnO using the original experimental descriptors from (Sayes and Ivanov, 2010). 527 
They distinguished toxic (leaking or disrupted membrane) instances using an LDH cut-off value 528 
of 1.09.  529 
In conclusion, several linear and non-linear models have been applied for the prediction of 530 
membrane integrity in different metrics (binary, nominal, numerical), mostly for metal oxides 531 
(mostly ZnO and TiO2) in human lung cells. Decision tree models were used for in vivo rodent 532 





Figure 10. Case flow by attribute, featuring cell viability as outcome. The width of the flows is 535 
proportional to the number of cases. The flow demonstrates what cell lines of which species were 536 
exposed to which particles, in in vivo or in vitro experiments, resulting in affecting cell viability. It also 537 
shows what models were used for predicting cell viability, codified as either a binary, numerical or 538 
nominal outcome. Liter: literature, Exper: experimental, Datab: database, Q-dots: quantum-dots, Dendr: 539 
dendrimers, Poly: polymers, comb 1 dataset containing carbon-based, metal, metal oxides, polymeric and 540 
dendrimers NPs, in viv-vit: dataset containing in vivo and in vitro data. 541 
        The majority of the studies modeling viability extracted information from literature (72 542 
cases). 27 cases were created using data from databases such as S2NANO and OCHEM. The 543 
most common NPs used in the datasets were metal oxides (49 cases) and combination of 544 
metals/metal oxides (35 cases). In vitro systems usually considered various species and multiple 545 
human cell lines (Table 4). For viability, a plethora of eco-toxicological endpoints using algae, 546 




models predicted viability in a binary form (68 cases) the rest in numeric (49 cases) (Figure 548 
10).  549 
 550 
 Table 4. Species (various in Figure 10) and cell lines (multiple in Figure 10) examples. 551 
Various 
(species) 
Human, mice, rat, organisms, bacteria, mouse, hamster, fish, dog, monkey, 
murine, rat, pig, canine, cow, among others. 
Multiple  
(cell lines or 
species 
details) 
lung, liver, kidney, intestine, bone marrow, areolar, prostate, heart, ovary, 
aorta, foreskin, gland, stomach, testis, urinary bladder, lymph node, 
lymphocyte intestinal, cardiovascular, alveolar macrophage, blood, glioma, 
bone, skin, brain, embryo, fibroblast, breast, colon, neutrophils, somatic cell 
hybrid, cervix, umbilical vein, dendritic cells, Staphylococcus aureus, 
Escherichia coli, zebrafish, Daphnia magna, Danio rerio, Pseudokirchneriella 




Comb1: dataset containing carbon-based, metal, metal oxides, polymeric 
and dendrimers NPs. 
Regarding data from databases, Trinh, et al. (2018b) performed data curation and meta-analysis 552 
for metals NPs to predict viability in a binary form (cut-off value of 50%). They implemented 553 
decision tree (Random Forest, RF) and instance based (SVM) algorithms using several in vitro 554 
cell lines from different species, p-chem properties and experimental conditions. Trinh, et al. 555 
(2018) predicted the impact of carbon-based NPs on viability of human lung cell lines using 556 
SMILES-based QSAR and RF. Metal oxides from the S2NANO database and several cell lines 557 
were tested implementing linear and non-linear modelling to predict viability either in binary 558 
(Choi, et al., 2018) or numeric form (Choi, et al., 2019). The above studies provided the curated 559 




datasets used). Kovalishyn, et al. (2018) gathered data on NPs toxicity in different organisms 561 
and cell lines and uploaded them on OCHEM. They used decision tree, instance based and 562 
neural network algorithms to predict viability in a binary form. Puzyn, et al. (2011) used new 563 
data generated experimentally and data from (Hu, et al., 2009) to predict numeric bacteria 564 
viability (log1/EC50) of metal oxides. They developed a QSAR model using multiple regression 565 
combined with a genetic algorithm (Puzyn, et al., 2011). The genetic algorithm selected the 566 
optimal descriptors from the ones already calculated by the regression model.  567 
The majority of the models were based on in vitro assays (88 cases) as shown in Figure 10, and 568 
a portion (18) were based on combination of in vivo/in vitro experiments. Twelve cases focused 569 
on in vivo systems predicting binary viability after exposure on metals/metal oxides 570 
(Kovalishyn, et al., 2018, Chen, et al., 2016). Chen, et al. (2016) studied hazard categorization 571 
for regulatory purposes using SARs based on information gathered from OCHEM. They 572 
retrieved multi-source eco-toxicity data and applied four decision tree algorithms across 573 
(various) species and species-specific (fish, bacteria) models. They predicted binary viability 574 
defined on an arbitrary threshold (active and inactive from LC50, EC50 and MIC data). 575 
Numerous studies focused in viability used data derived from assays of different cell lines from 576 
various species (human, fish, algae, rodent, bacteria, etc., see Table 4).  577 
Toropova, et al. (2015) predicted viability for SiO2 using data from human and porcine renal 578 
tubular kidney cells applying quasi-QSAR model based on eclectic data and SMILES.  Hamster 579 
ovary cell line data were used for the numerical  prediction of TiO2 NPs log(1/EC50) viability 580 
using multiple linear regression analysis in (Mikolajczyk, et al., 2018). Four bayesian networks 581 
cases were developed to predict viability of quantum dots (Bilal, et al., 2019), metal oxides 582 
(Furxhi, et al., 2019a) and dendrimers (Jones, et al., 2015). While bayesian networks offer many 583 
advantages such as, visual representation of the model, correlation among inputs, user 584 




in the field (Murphy, et al., 2016, Marvin, et al., 2017, Furxhi, et al., 2019b). (Bilal, et al., 2019) 586 
predicted numerical viability of Cd-containing quantum dots as percentage and  IC50 (expressed 587 
into log10) using Bayesian Networks, including web-based model versions with outcomes 588 
discretized in bands. Jones, et al. (2015) tested the ability of a variety of algorithms (Bayesian 589 
Networks, meta, regression, instance based, rules) to predict binary viability of human colon 590 
cells exposed to poly(amido amine) (PAMAM) dendrimers. 591 
5 Discussion 592 
In this paper, we provided an overview of nanotoxicology cases that implement machine 593 
learning methods to predict human health and ecotoxicological hazard endpoints, highlighting, 594 
for the top five most predicted outcomes the biological level of organization. We did not 595 
compare machine learning algorithms and the actual results of the models. Different approaches 596 
cannot be easily compared due to the diversity of input choices and datasets, even for the same 597 
outcome. However, several methodologies have been proposed to rank and compare classifiers 598 
according to their predictive performance (Furxhi, et al., 2019a, Tamvakis, et al., 2018, Tsiliki, 599 
et al., 2015). 600 
The studies presented here were not reviewed regarding their compliance to the fifth OECD 601 
principle, that is, having included a mechanistic interpretation; the goal of the manuscript was 602 
not to critically assess available tools but rather to provide a synthetic overview of the machine 603 
learning tools in nanotoxicology based on the biological organization level. 604 
5.1 Practices of current studies 605 
5.1.1 Data sources in the studies 606 
         The majority of the reviewed studies extracted data from peer-reviewed literature sources 607 
as demonstrated in section 4.1. Available computational approaches were not build as much on 608 




from eNanoMapper (Helma, et al., 2017). This can be attributed to the fact that most of those 610 
databases are, for the moment, not nano-specific e.g., the OCHEM database contains nano and 611 
non-nano experimental data. ENanoMapper is an ongoing project, integrating research data 612 
from various relevant projects and literature, expected to deliver results in the near future. Most 613 
endpoints derived from databases were used for modeling ecotoxicity. This indicates that there 614 
are more data publicly available suitable for ecotoxicity endpoints than human health hazard 615 
endpoints. Over 200 in vivo assessments for NP toxicity in embryonic zebrafish model can be 616 
found in the NBI. Almost all database derived data regard metal and metal oxide NPs. 617 
5.1.2 Nanoparticle and study design information 618 
        There has been a trend of developing toxicity models for metal oxides and metals or 619 
combined metals/metal oxides NPs as demonstrated in section 4.1, due to the growing 620 
popularity of using metal and metal oxide NP in commercial products (Vance, et al., 2015). 621 
Still, there are no studies reporting cytotoxicity prediction for quite a few NP types such as 622 
micelles, liposomes, dendrimers, mixtures and polymeric NPs. Carbon-based, polymeric or 623 
dendrimer NP eco-toxicity modelling is also missing. 624 
Roughly half of the approaches reviewed included nanospecific descriptors in the final model, 625 
while the other half included calculated theoretical descriptors as input variables, either used as 626 
such, or in combination with p-chem characteristics. The most common p-chem attributes 627 
include size either as primary or aggregated size, zeta potential and surface area. In vitro 628 
experimental conditions such as cell type, origin or toxicological assay were less commonly 629 
included. Size, shape, zeta potential, surface area and composition are among the most 630 
commonly used, or recommended to be used, nano-features for a toxicological evaluation 631 
though a broad scientific consensus on the set of required features is still missing (Oksel, et al., 632 
2015b). Defining the significant drivers of toxicity among the various NP p-chem is challenging 633 




to toxicity is demanding as (eco) toxicity can be affected by changes in a property in a non-635 
trivial manner. It is worth noting that the new, relevant to nanoforms, revisions of the Annexes 636 
of the European Union’s chemical legislation demand that, quoting Clausen and Hansen (2018), 637 
“Thou shalt not use molecular structural similarities alone as a justification for grouping 638 
different nanoforms”. This decree signifies the importance of incorporating nano-specific 639 
features in a model. 640 
         The majority of the studies created in silico tools from in vitro toxicological data as 641 
demonstrated in section 4.2. One of the general limitations of in vitro test systems is that they 642 
are restricted to one or a few different cell types and, thus, cannot represent the biological 643 
responses in the whole organism. Furthermore, these systems are usually derived from cancer 644 
cell lines which can result in different outcomes when compared to in vivo tests. To tackle this 645 
issue, cell type and cell origin can be accounted for as input variables in the model (Choi, et al., 646 
2018, Furxhi, et al., 2019a). Evidently, the number of in vivo modelling was low; 10 out of 86 647 
studies were performed with an in vivo system (rodent, fish, crustacean or combination of 648 
organisms). Those tendencies reflect ethical and economic considerations, channeling research 649 
resources towards the development of toxicity test alternatives, such as in vitro.  650 
Aggregated outcomes prediction is mostly found in cases of various species (human and 651 
ecotoxicological) and multiple cell lines, as demonstrated in section 4.2. Apoptosis outcome 652 
models used human cell lines of liver, aorta, blood and muscle. Cellular uptake is predicted 653 
mostly for human pancreatic cell lines while membrane integrity is commonly predicted for 654 
rodent lung cell lines. For the three latter outcomes, there has been no tool developed for 655 
ecotoxicological prediction. Viability, the most abundantly predicted outcome using machine 656 
learning is predicted for various ecotoxicological species, human and various other species, in 657 
multiple cell lines such as lung, colon, blood and skin. A few models used in vitro experimental 658 




in vitro studies will fall short to capture the impact on the predicted toxicity of the experimental 660 
conditions variations, corresponding to differences in biological organization levels. It is 661 
notable that no machine learning tool was applied to predict neurotoxicological outcomes. 662 
Single exposures are typically used in in vitro studies which usually last from a few minutes up 663 
to a few days depending on the endpoint tested. Therefore, chronic exposure cannot be tested 664 
sufficiently. Defining a suitable dose range is a challenge for both in vitro and in vivo tests as 665 
often unrealistically high doses are chosen in order to observe an effect. As demonstrated in 666 
section 4.1, exposure dose and duration have not been frequently used as input variables and 667 
their effect on the predicted outcome has not been appropriately modelled. When dose is 668 
included, it is ranked as a significant feature for the prediction of the outcome (Choi, et al., 669 
2018, Furxhi, et al., 2019b). 670 
5.1.3 Studies Endpoints 671 
         A well-defined endpoint is essential for clarity regarding what is being predicted by a 672 
model. A range of specific considerations for evaluating an endpoint include the scientific 673 
purpose, the quality of the assays and experimental protocol(s); the units of measurement, the 674 
underlying data and the regulatory relevance of the endpoint (Puzyn, et al., 2018). QSARs were 675 
developed mostly for cytotoxicity endpoints which are not endpoints included in REACH. 676 
REACH toxicological endpoints such as on acute toxicity, repeated dose toxicity, sensitization, 677 
carcinogenicity or reproductive toxicity are not covered by models developed so far. The most 678 
common endpoints evaluated in literature were measured as cellular viability, membrane 679 
damage, cellular uptake and apoptosis, as shown in section 4.1. All relevant models for cellular 680 
uptake used the same original dataset which describes the cellular uptake of cross-linked iron 681 
oxide NPs by pancreatic human cancer cells. Generic aggregated endpoints were commonly 682 
used, an example of the trade-off between data availability and data quality. One third of the 683 




5.1.4 Model implementation 685 
         Trees, neural network and regression algorithms are abundant compared to rules, bayes, 686 
or meta algorithms as demonstrated in section 4.2. Most of the modelling, for all categories of 687 
NPs, has focused on the traditional implementation of QSAR or SAR. There are two alternative 688 
approaches namely quasi-QSARs and perturbation models that compared to classical models, 689 
handle and exploit available data differently. Those promising approaches focus on extracting 690 
more information from datasets than traditional approaches do and meet the latest regulation 691 
requirements as they incorporate several experimental features. 692 
Experimental conditions affect the observed outcomes, hence it is essential to include this 693 
dependent information in a QSAR model. In quasi-QSARs the endpoint is associated to NPs 694 
through a mathematical function of available eclectic data; those data include biochemical 695 
parameters (synthesis), exposure conditions (dose and duration of exposure, bio targets such as 696 
cells, species, organisms) and p-chem properties that affect the outcome (Toropova, et al., 697 
2015b, Choi, et al., 2019). In contrast, traditional models are mathematical functions of 698 
molecular structures. In quasi-QSAR the eclectic data are represented in the quasi-Simplified 699 
Molecular Input-Line Entry System (SMILES) which comprises character-based strings 700 
representations of a series of simple syntactic sequences (Trinh, et al., 2018). In the case of 701 
continuous data, the data can be normalized and discretized into subintervals. As the number of 702 
codes in the quasi-model decreases so does the sensitivity of quasi-QSAR (Toropova, et al., 703 
2015). An improved quasi-SMILES code assignment method was proposed to tackle the issue 704 
using hierarchical cluster analysis (Trinh, et al., 2018). Similarity between numerical 705 
descriptors is used to group the codes to a number of groups before the eclectic data are 706 
translated into optimal nano-descriptors (the sum of weights of the quasi-SMILES). An 707 
alternative to calculate the optimal descriptors is using Monte Carlo from arbitrary eclectic 708 




experimental data. The quasi-SMILES provide a suitable framework for developing predictive 710 
models for NPs since all available eclectic data that impact toxicity can be integrated and the 711 
impact of descriptors on toxicity can be evidently seen (Choi, et al., 2019). Using eclectic data 712 
increases the number of available datasets which is a fair advantage of quasi-SMILES in the 713 
case of nanotoxicology lack of data. 714 
Until now, QSARs and quasi-QSARs have attempted the prediction of one outcome usually 715 
against one biological entity/system (e.g. cell line, fish, bio-indicator etc.) based on classical 716 
approaches and small datasets. However, there is a need for models that predict the toxicity of 717 
NPs in different organisms/bio-indicators and diverse experimental conditions. A promising 718 
approach based on perturbation theory has been proposed recently (Kleandrova, et al., 2014, 719 
Kleandrova, et al., 2017) which in conjunction with quasi-models can i) combine multiple nano-720 
descriptors (p-chem properties, key biological factors, interspecies, experimental conditions) 721 
using the moving average approach and ii) simultaneously predict several multiple toxicity 722 
(cytotoxicity and ecotoxicity) endpoints. Considering the large number of new NPs and the 723 
safety obligations from regulatory agencies requiring toxicity data in multiple species or 724 
toxicity endpoints, perturbation models are able to handle interspecies prediction of multiple 725 
toxicity endpoints. This significantly limits resources demands, including time needed for 726 
evaluating the toxicity of new NPs (bridging data gaps) and may speed up regulatory decisions 727 
(Luan, et al., 2014, Basant and Gupta, 2017). Interspecies modeling reduces testing on higher 728 
level organisms and contributes to mechanism of action interpretation (De, et al., 2018). In 729 
classic QSARs and quasi-QSARs each case constitutes one single prediction in the data set and 730 
the intercept of the equation is often considered as the value of reference. Any case, though, 731 
can be used as reference and neglecting this affects model reliability (Kleandrova, et al., 2014b). 732 
Perturbation models use random pairs of features where each feature is used many times as 733 




Contrary to classical models this leads to more realistic predictions and at the same time 735 
increases the number of data cases dramatically (Kleandrova, et al., 2014, Kleandrova, et al., 736 
2017). The moving average approach uses perturbations of traditional features (molecular 737 
information) around same features averages in different experimental conditions in order to 738 
calculate a new set of toxicological encoded descriptors (González-Durruthy, et al., 2017). In 739 
addition, by using relative values instead of absolute ones this methodology is sensitive to the 740 
finer modifications of descriptors, thus offering refined information compared to traditional 741 
data handling. (González-Durruthy, et al., 2017). While perturbation models mentioned in the 742 
literature has been mostly linear, as the interaction of NPs with biological systems is complex, 743 
novel perturbation models using non-linear approaches (neural networks) has been also 744 
developed (Concu, et al., 2017).  745 
Simultaneous prediction of multiple outcomes has been achieved by another non-linear 746 
algorithm, bayesian networks (Furxhi, et al., 2019b, Furxhi, et al., 2018). The authors used 747 
feature correlation results among p-chem properties, experimental exposure conditions and in 748 
vitro characteristics in order to manually craft a Bayesian structure, similarly to (Bilal, et al., 749 
2019). They predicted nine different biological effects on a molecular level using outcomes of 750 
transcriptomics studies such as cell cycle and proliferation responses or cell death and apoptosis 751 
responses. That was the first non-perturbation model that simultaneously predicted outcomes 752 
without using aggregated nodes that cluster the toxicological effects into one class. Clustering 753 
several effects in one outcome, the norm for Bayesian Networks application in nanotoxicology, 754 
disregards the differentiation of attribute importance in predicting  different toxicological 755 




5.2 Challenges and Perspectives 757 
5.2.1 Qualities and integration 758 
          Predicting (eco) toxicological effects of NPs by means of in silico tools requires access 759 
to high quality (meta) data. Data gathered or generated can be reused from different 760 
stakeholders; however, only 27% of studies provided accessibility of data in supplementary 761 
spreadsheets. Cell culture conditions and methodology, NP preparation and all elements and 762 
stages of experimental design and laboratory conditions should be clearly described either when 763 
set to be used by QSAR or by any computational tool, to ensure compliance to the second 764 
OECD principle, enabling interpretability of data and comparability with other studies (Puzyn, 765 
et al., 2018). Still, the question of experimental quality guidelines, standard procedures, 766 
sufficient characterization, dosimetry issues and the “reproducibility crisis” remain in the field 767 
(Donaldson, et al., 2013, Poland, et al., 2014, França and Monserrat, 2018). (Oksel, et al., 2017, 768 
Oksel, et al., 2015b) provided a critical review of the availability of NP characterization and 769 
toxicity data meeting the requirements for in silico analysis. The data curation topic, one of the 770 
major issues highlighted in recent review papers of nanotoxicity prediction, has been studied 771 
by a number of collaborative consortia. A series of studies focused on aspects of data curation, 772 
such as the workflow, data completeness, quality and the role of data curation in 773 
nanoinformatics (Hendren, et al., 2015, Powers, et al., 2015). This review does not critically 774 
assess data curation issues, techniques or methods, but stresses their importance. Those issues 775 
are addressed elsewhere, especially in the Nanomaterial Data Curation Initiative (NDCI) 776 
(Basei, et al., 2019, Trinh, et al., 2018b, Hendren, 2015, Karcher, et al., 2018, Quik, et al., 777 
2018). 778 
ISA-TAB-nano (and upgrades to ISA-JSON) standard formats were developed aiming at 779 
creating a global authoritative database for easily accessible and transferable data from different 780 




files and to enforce the specification are available, as demonstrated by the introduction of “ISA-782 
Tab-logic” templates (Haase, 2018). Marchese Robinson, et al. (2015) provided a generic ISA-783 
TAB-Nano that serve as a starting point for the construction of nanotoxicology datasets. 784 
However, the authors note that guidance regarding the different kinds of (meta)data is required, 785 
due to the necessity of having p-chem and toxicological information in one dataset, in order to 786 
facilitate the predictive nanotoxicology and to enable safe-by-design approaches. Thus, it would 787 
be wise, for any new experimental data generated to use a nano-format to enable future 788 
integration to either datasets or databases. An integration and a reuse of data will also 789 
necessitate common terminologies; several tools have already been developed using ontologies 790 
to integrate different data sources. Haase (2018) provided an overview of generic ontology 791 
tools. Córdoba and Zambon (2017) proposed a novel ontological category of nanoindividuals, 792 
as a recommendation for the stepwise procedure for chemical categories proposed by OECD. 793 
The databases will finally integrate into a single database with highly curated (meta) data 794 
available for computational toxicology. This course will eventually lead to the acceptance of in 795 
silico tools in regulatory bodies in compliance with the 3Rs movement. Datasets and/or 796 
databases integration will also generate new hypotheses and knowledge and will benefit 797 
multiple stakeholders (Karcher, et al., 2018). In the paper ibid, the authors highlight the 798 
importance of data integration in nanotechnology and provide recommendations for advancing 799 
integration.  800 
Haase (2018) provided a summary of available nano-specific databases. In parallel, Basei, et 801 
al. (2019) provided 16 nano-specific databases while critically addressing their accessibility to 802 
the public and data containment. Karcher, et al. (2018) also commented on accessibility, 803 




ontologies. GRACIOUS14, an ongoing project, will integrate available databases into a singular 805 
database15 addressing data curation to develop a scientific framework for grouping, read-across 806 
and classification of NPs. Similar efforts for curating and integrating existing data are being 807 
conducted in international projects such as NanoFASE16, Nano-Commons17 and ACENano18.  808 
Another database, the S2NANO19, although including various experimental results related to 809 
NPs obtained from different sources achieved little visibility in recent review studies (Lamon, 810 
et al., 2019, Basei, et al., 2019, Saini and Srivastava, 2018). S2NANO addresses issues of data 811 
quality and completeness using a p-chem score screening system and a data gap filling method 812 
based on manufacturer’s specifications and/or estimations (Trinh, et al., 2018b, Ha, et al., 813 
2018).  814 
Similar to S2NANO, platforms like eNanoMapper are being created as means for collection 815 
and curation of data to establish completeness and quality (Basei, et al., 2019). The Cancer 816 
Nanotechnology Laboratory data portal (caNanoLab)20 is a collaborative effort between three 817 
NCI interdisciplinary research centers, to integrate global research data sources. caNanoLab 818 
serves as a data repository that allows researchers to submit and retrieve information on well-819 
characterized NPs including compositions; p-chem, in vitro and in vivo characteristics, 820 
associated publications and assay protocols (Grodzinski, et al., 2019). 821 
5.2.2 Emerging infrastructures 822 
Concerning the sparsity and heterogeneity of available data, the EU has funded projects to 823 
address data quality and accessibility. Concurrently, the integration of computational platforms 824 
                                               
14 https://www.h2020gracious.eu/ (Webpage accessed autumn 2019). 
15 (https://apps.ideaconsult.net/gracious/ui) (Webpage accessed autumn 2019). 
16 http://www.nanofase.eu/ (Webpage accessed autumn 2019). 
17 https://www.nanocommons.eu/ (Webpage accessed autumn 2019). 
18 http://www.acenano-project.eu/ (Webpage accessed autumn 2019).  
19 (http://portal.s2nano.org/) (Webpage accessed autumn 2019). 




will allow different stakeholders to explore data by means of in silico tools. H2020 825 
NanoCommons21, a new project, addresses data accessibility (data on toxicity, characterization, 826 
protocols etc.,). The project applies quality assurance criteria while underpinning ontologies to 827 
create an in silico framework and infrastructure for NP safety assessment. NanoInformaTIX22 828 
develops a platform for risk management of NP based on p-chem and toxicological data already 829 
generated, as well as data currently produced in ongoing projects. The data will be stored in a 830 
database operated by the project. NanoSolveIT23 will collect publicly available data from 831 
different sources, curate, harmonize, FAIRify (assure Findability, Accessibility, 832 
Interoperability, and Reusability) and integrate existing and emerging data on characterization, 833 
release, exposure, biological and toxicological effects on human health and the environment. 834 
In addition, targeted datasets will be delivered to gap-fill incomplete datasets and models after 835 
collation and procurement of all data available via consortium partners. 836 
Nano-specific databases are still in research stage. Data are generated experimentally following 837 
different procedures. In order to build reliable datasets standard protocols should be followed, 838 
datasets should be adequately large and values should be suitable for computational use 839 
(Villaverde, et al., 2018). There is a significant amount of nano-relevant datasets unstructured 840 
and scattered. There are ongoing efforts to fuse data from different sources, facing difficulties 841 
due to   lack of standardized access and broad agreement on codifications of NPs and related 842 
data. Common language is being developed, but the computational nanotoxicology community 843 
is still developing consensus on conceptualization and communication of the field elements and 844 
their associations. 845 
                                               
21 https://www.nanocommons.eu/ (Webpage accessed autumn 2019). 
22 http://www.nanoinformatix.eu/ (Webpage accessed autumn 2019). 





6 Conclusion 846 
This literature review in nanotoxicology field predicting human health and eco-toxicological 847 
endpoints identified several machine learning models that provide prediction to numerous 848 
nanotoxicological outcomes and supports the notion that data availability and curation are still 849 
the main issues faced by the computational toxicology community. The main conclusion of our 850 
analysis is that most studies perform modelling for few NPs, extracting data mainly from the 851 
literature and test in various in vitro systems and multiple cell lines. Several novel 852 
computational approaches such as perturbation models or quasi-QSARs can help to build 853 
biologically more accurate models since they capture the impact on the outcome of exposure 854 
conditions and other experimental parameters. Perturbation models also provide a solution for 855 
small datasets, which is a major issue in in silico approaches. Databases facilitation and 856 
multisource data extraction is still under development but set recently as a priority in research 857 
community, so highly curated data are expected to be shortly available blooming the area of 858 
computational nanotoxicology. Ongoing efforts and further research will advance as 859 
computational tools are developed and implemented and might shade light in the key properties 860 
that ultimately affect NPs toxicity, offering safe-by-design criteria for a promising 861 
nanotechnological era. 862 
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